Medline’s shares rose 18.4% after earnings, with investors responding to 10% sales growth and 12% growth in adjusted EBITDA. The quarter also showed margin pressures from inflation, customer mix, and higher operating expenses, while management flagged near-term pressure and ongoing quality investments.
Medline’s shares dropped 17.9% following an outlook moderation driven by operational headwinds including the Tracy warehouse fire, quality remediation costs, and softness in the retail segment, which overshadowed strong sales growth and new customer wins.